Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation ...
Apalutamide has shown significantly increases in radiographic progression-free survival (rPFS) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) patients diagnosed by conventional imaging (CI). However, there is scarce …